News in the Life Sciences Industry

SEOUL, South Korea, Sept. 17, 2020 /PRNewswire/ -- Medit announces the launch of three new T-Series laboratory scanner models; T710, T510, and T310.

STOCKHOLM, Sept. 17, 2020 /PRNewswire/ -- Enzymatica distributed the press release about the result from its placebo-controlled, randomized study in Germany on August 17th. In this version the company referred incorrectly in the quote by Claus Egstrand that the results from the study confirmed... Read more ››

STOCKHOLM, Sept. 17, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on September 17 2020, that the first patient in Sweden is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac").

LUND, Sweden, Sept. 17, 2020 /PRNewswire/ -- Hansa Biopharma ("Hansa"), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company will host its 2020 Capital Markets Day (CMD) in Copenhagen on Thursday October 29, from 13:30-17:30 CET (7:30am-11:30am... Read more ››

STOCKHOLM, Sept. 17, 2020 /PRNewswire/ -- INVISIO has, through its U.S. GSA contract, received an order for SEK 44 million from an existing customer within the U.S. Department of Defense (DoD). The order includes advanced communication and hearing protection solutions. Delivery will be during... Read more ››

LINKÖPING, Sweden and SHELTON, Conn., Sept. 17, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››

STOCKHOLM, Sept. 16, 2020 /PRNewswire/ -- Diamyd Medical announced earlier this week that the diabetes vaccine Diamyd(®) has demonstrated significant effect in a subgroup which covers about half of all type 1 diabetes patients. In connection to this, CEO Ulf Hannelius together with the trial's... Read more ››

STOCKHOLM, Sept. 16, 2020 /PRNewswire/ -- Apply to The European Training Network PHAST (Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy). Maybe you will be one of 15 Early Stage Researchers (ESRs) which will be enrolled in a strong multidisciplinary PhD programme.

STOCKHOLM, Sept. 16, 2020 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based... Read more ››

LUND, Sweden, Sept. 16, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,774,150 which covers compositions of matter directed to Alligator's bispecific drug candidate... Read more ››

- Elekta Harmony to shorten treatment times and reduce footprint while maintaining high precision

UPPSALA, Sweden, Sept. 14, 2020 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces it has filed a patent infringement action in the United States District Court for the District of New Jersey with docket number 3:20-cv-12588, against Sun Pharmaceutical Industries... Read more ››

VIKEN, Sweden, Sept. 14, 2020 /PRNewswire/ -- A new study on TIKOMED's lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain... Read more ››

VIKEN, Sweden, Sept. 14, 2020 /PRNewswire/ -- A new study on TIKOMED's lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain... Read more ››

STOCKHOLM, Sept. 14, 2020 /PRNewswire/ -- On 31 August 2020, Implantica AG([1]) ("Implantica", the "Company" or the "Group"), a medtech group with operations within the implantable medical device and eHealth markets, announced its intention to conduct an offering to the public of Swedish... Read more ››

STOCKHOLM, Sept. 14, 2020 /PRNewswire/ -- Diamyd Medical today announced the topline results from the placebo-controlled Phase IIb trial DIAGNODE-2, where the diabetes vaccine Diamyd(®) (GAD-alum) was injected directly into a lymph node in individuals with recently diagnosed type 1 diabetes.... Read more ››